IL17A and cancer: The KEGG pathway enrichment confirmed the significant enrichment of DEGs in the IL-17 signaling pathway, malaria, TNF signaling pathway, African trypanosomiasis, rheumatoid arthritis, AGEs-RAGE signaling pathway in diabetic complications, NF-κB signaling pathway, Th17 cell differentiation, transcriptional misregulation in cancer, pertussis.